missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ TACC1 Polyclonal Antibody
GREENER_CHOICE

Rabbit Polyclonal Antibody

Brand:  Invitrogen™ PA599235

Product Code. 16653485

  • £448.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Antibody detects endogenous levels of total TACC1.

This locus may represent a breast cancer candidate gene. It is located close to FGFR1 on a region of chromosome 8 that is amplified in some breast cancers. Three transcript variants encoding different isoforms have been found for this gene.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

TACC1
Polyclonal
Unconjugated
TACC1
4833447E04Rik; AA960202; B230378H13Rik; Ga55; gastric cancer antigen Ga55; KIAA1103; Tacc1; Tacc1a; Taxin-1; transforming acidic coiled-coil containing protein 1; transforming acidic coiled-coil-containing protein 1; transforming, acidic coiled-coil containing protein 1; transforming, acidic coiled-coil containing protein 1a
Rabbit
Affinity Chromatography
RUO
320165, 6867
-20°C
Liquid
Western Blot, Immunocytochemistry
1 mg/mL
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
O75410, Q6Y685
TACC1
A synthesized peptide derived from human TACC1(Accession O75410), corresponding to amino acid residues A21-R71.
100 μL
Primary
Human, Mouse
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.